原人参二醇空心金纳米药物载体的制备及体外抗喉癌研究

原人参二醇(PPD)对多种肿瘤细胞具有抑制作用。但由于水溶性差、利用度低,限制了其在临床上的应用。基于此,本研究以空心金纳米颗粒为PPD的运输载体,合成PPD空心金纳米颗粒,采用高效液相色谱分析PPD空心金纳米药物载体的缓释效应性、MTT法检测对Hep-2细胞增殖的抑制作用、流式细胞术研究对Hep-2细胞凋亡的影响,以考察原人参二醇(PPD)空心金纳米药物载体的体外抗喉癌细胞Hep-2效应。结果表明,PPD空心金纳米药物载体具有缓释效应性,与空白对照组、HAu Ns组及PPD组相比,HAu Ns-PEGPPD组的Hep-2细胞生存率下降更显著,细胞凋亡率增加更显著(p0.01)。PPD空心金纳米载体可显著增强PPD的体外抗喉癌细胞效应,促进肿瘤细胞的凋亡,有望成为PPD新型纳米药物,并应用于喉癌的治疗研究。     

无种子法纳米金棒的制备及其对肿瘤细胞光热治疗效应研究

采用简便快捷的无种子法一步完成了纳米金棒的制备. 通过改变实验条件可以调控纳米金棒的吸收峰从可见到近红外转移. 将巯基聚乙二醇（PEG-SH）置换金棒表面的十六烷基三甲基溴化铵（CTAB）分子,大大提高了金棒的生物相容性. 制备的纳米金棒在近红外（NIR）光照射下对肿瘤细胞有很好的杀伤效果.研究结果为纳米金棒用于抗肿瘤治疗提供了实验基础.     

无种子法纳米金棒的制备及其对肿瘤细胞光热治疗效应研究

采用简便快捷的无种子法一步完成了纳米金棒的制备.通过改变实验条件可以调控纳米金棒的吸收峰从可见到近红外转移.将巯基聚乙二醇(PEG-SH)置换金棒表面的十六烷基三甲基溴化铵(CTAB)分子,大大提高了金棒的生物相容性.制备的纳米金棒在近红外(NIR)光照射下对肿瘤细胞有很好的杀伤效果.研究结果为纳米金棒用于抗肿瘤治疗提供了实验基础.     

BiOCl纳米片微球的制备及其形成机理

以乙二醇为溶剂,采用溶剂热法制备了BiOCl纳米片微球.BiOCl纳米片交织在一起,形成开放的微孔结构.不同条件下合成的BiOCl形貌分析表明,纳米片微球的形成是乙二醇辅助生长的过程:乙二醇的2个氧原子与1个或2个铋离子配位生成含铋多聚络合物.在溶剂热过程中,Bi3+离子催化乙二醇聚合脱水,生成的水分子反过来原位促进金...     

叶酸高分子纳米胶束在小鼠体内的靶向分布

合成了带有叶酸靶向和荧光染料的聚合物FA-PEG-PLA和mPEG-b-P（LA-co-MHC／NIR）,通过混合胶束的方法制备近红外染料胶束P（NIR）（含染料NIR6％）,叶酸胶束FA-P（NIR）1（含染料NIR5．4％,叶酸LFA0．5％）和叶酸胶束FA-P（NIR）2（含染料NIR4．8％,叶酸FA0．9％）;建立了H22肝癌小鼠模型,考察了高分子纳米胶束及叶酸靶向纳米胶束在H22肝癌小鼠体内分布．结果表明,高分子纳米胶束及叶酸靶向纳米胶束在小鼠体内分布都具有时间相关性,无叶酸配体的高分子纳米胶束在尾静脉注射24h后在肿瘤部位有少量聚集,大部分胶束在肝部聚集,30h内大部分已被排泄系统排出体外;含有叶酸配体的纳米胶束在尾静脉注射后6-30h内在肿瘤部位有明显的聚集,其中,FA-P（NIR）1胶束在肿瘤和肝部位的聚集相当,FA-P（NIR）2胶束在静脉注射24h后在肿瘤聚集明显高于肝部．带有叶酸配体的高分子纳米胶束相对于不带叶酸配体的纳米胶束在小鼠肿瘤部位具有明显的聚集,并且随着叶酸含量的增大,聚集效果更明显．     

利用光热电效应收集近红外光能的二硫化钼和热释电高分子纳米复合物（英文）

设计合成了一种基于二硫化钼(MoS_2)/热释电聚合物的柔性薄膜光热电纳米发电机(PTENG)。过渡金属硫族化合物作为薄层纳米薄片,可以捕获近红外(NIR)光,并将其转化为热能。同时,热释电聚合物将无机纳米片所收集的热能转化为电能。在近红外辐照下,PTENG可以瞬间产生电压和光电流,且输出长期保持在较高水平。通过光热效应与热释电效应的有效耦合,该体系具有较高的热电转换系数。我们还通过理论模拟分析了MoS_2在聚合物纳米复合材料中的作用。MoS_2的存在显著提高了热释电聚合物薄膜的温度变化率,提高了器件的光电响应。     

不同维度Co3O4纳米材料的水热合成研究进展

过渡金属氧化物Co_3O_4的晶体结构及表面特性与其形貌、尺寸和微观结构密切相关。本文将不同形貌Co_3O_4纳米材料按尺寸分为:纳米球、立方块、多面体等零维材料,纳米线、纳米棒、纳米管、纳米柱等1D材料,纳米片、纳米薄膜等2D材料,海胆状、微米球等由纳米单元构成的微米尺寸3D超结构。探讨了对形貌形成的影响因素,重点研究其水热合成过程,总结了可能的形成机理,以利于对不同维度材料的形成规律有较深入的理解,进而能在理论上指导特定维度、特定形貌材料的可控合成。     

金＠壳聚糖复合材料的合成、表征及其葡萄糖选择氧化性能

采用硼氢化钠化学还原氯金酸的碱性溶液制备了纳米金溶胶, 利用紫外-可见吸收光谱研究了金与壳聚糖的相互作用. 结果表明, 壳聚糖能够捕获金纳米粒子并易于形成金@壳聚糖复合材料. 利用X-光粉末衍射(XRD)、紫外-可见漫反射光谱(UV-vis DRS)、透射电镜(TEM)、红外光谱(IR)、微分热重及差热分析(DTG-DTA)等对这种复合材料进行了表征, 发现该材料具有较小的金纳米粒子, 壳聚糖的存在改变了金纳米粒子的等离子共振吸收, 二者之间存在一定的键合作用. 以分子氧为氧化剂, 在温和条件下, 该材料对葡萄糖选择氧化制葡萄糖酸反应具有良好的催化性能.     

利用光热电效应收集近红外光能的二硫化钼和热释电高分子纳米复合物

设计合成了一种基于二硫化钼（MoS₂）/热释电聚合物的柔性薄膜光热电纳米发电机（PTENG）。过渡金属硫族化合物作为薄层纳米薄片,可以捕获近红外（NIR）光,并将其转化为热能。同时,热释电聚合物将无机纳米片所收集的热能转化为电能。在近红外辐照下,PTENG可以瞬间产生电压和光电流,且输出长期保持在较高水平。通过光热效应与热释电效应的有效耦合,该体系具有较高的热电转换系数。我们还通过理论模拟分析了MoS₂在聚合物纳米复合材料中的作用。MoS₂的存在显著提高了热释电聚合物薄膜的温度变化率,提高了器件的光电响应。     

基于对硝基苯酚还原模型反应的纳米金催化材料

硝基苯酚是工业和农业废水中常见的有机污染物之一。近年来,由于纳米金催化材料的优异催化性能,纳米金催化材料日益成为催化还原对硝基苯酚的一种高效、快速和环境友好的催化材料;合成高度分散、尺寸均一、稳定、易分离及可重复使用的纳米金催化材料是该领域的研究重点。本文以纳米金催化材料的整体结构为主线,归纳了纳米金催化材料的最新研究进展;重点讨论了纳米金催化材料的制备手段及其催化活性、稳定性、可回收性和可重复使用性;并对纳米金催化材料的发展方向和今后需解决的关键问题进行了展望。     

Selective photothermal therapy for mixed cancer cells using aptamer-conjugated nanorods

Safe and effective photothermal therapy depends on efficient delivery of heat for killing cells and molecular specificity for targeting cells. To address these requirements, we have designed an aptamer-based nanostructure which combines the high absorption efficiency of Au-Ag nanorods with the target specificity of molecular aptamers, a combination resulting in the development of an efficient and selective therapeutic agent for targeted cancer cell photothermal destruction. Most nanomaterials, such as gold nanoshells or nanorods (NRs), require a relatively high power of laser irradiation (1 x 10 (5)-1 x 10 (10) W/m (2)). In contrast, the high absorption characteristic of our Au-Ag NRs requires only 8.5 x 10 (4) W/m (2) laser exposure to induce 93 (+/-11)% cell death of NR-aptamer-labeled cells. Aptamers, the second component of the nanostructure, are generated from a cell-SELEX (systematic evolution of ligands by exponential enrichment) process and can be easily selected for specific recognition of individual tumor cell types without prior knowledge of the biomarkers for the cell. When tested with both cell suspensions and artificial solid tumor samples, these aptamer conjugates were shown to have excellent hyperthermia efficiency and selectivity. Under a specific laser intensity and duration of laser exposure, about 50 (+/-1)% of target (CEM) cells were severely damaged, while more than 87 (+/-1)% of control (NB-4) cells remained intact in a suspension cell mixture. These results indicate that the Au-Ag nanorod combination offers selective and efficient photothermal killing of targeted tumor cells, thus satisfying the two key challenges noted above. Consequently, for future in vivo application, it is fully anticipated that the tumor tissue will be selectively destroyed at laser energies which will not harm the surrounding normal tissue.     

基于共轭聚合物的纳米粒子用于肿瘤的近红外二区荧光成像及光热治疗

为提高生物组织荧光成像质量以及对肿瘤的高效光热治疗,设计合成了一种新型的窄带隙共轭聚合物(BDT-TTQ),并通过纳米沉积的方式将聚合物制备成水溶性纳米粒子(BDT-TTQ NPs).该共轭聚合物纳米粒子在1000~1200 nm近红外二区范围具有较好的吸收,在1064 nm的激发光下能实现1200~1400 nm的近红外二区荧光成像. BDT-TTQ NPs纳米粒子粒径分布较窄,形貌呈规则的球形且分散均匀,具有好的生物相容性.该纳米粒子既可以在体外实现较高的近红外二区荧光成像穿透深度,又可以实现对小鼠活体血管的高清晰度的近红外二区荧光成像.此外,BDT-TTQ NPs纳米粒子在1064 nm激光下展现出优异的光热转换效率,具有较高的光毒性,对体外的肿瘤细胞以及小鼠的异质瘤具有高的光热杀伤能力.     

A photosensitizer-loaded zinc oxide-polydopamine core-shell nanotherapeutic agent for photodynamic and photothermal synergistic therapy of cancer cells

In clinical cancer research,it is quite promising to develop multimodal synergistic therapeutic strategies.Photodynamic and photothermal synergistic therapy is a very desirable multimodal therapy strategy.Herein,we report a facile and simple method to construct a nanotherapeutic agent for photodynamic and photothermal therapy.This nanotherapeutic agent(ZnO@Ce6-PDA)is composed of a ZnO nanoparticle core,an interlayer of photosensitizer chlorin e6(Ce6)and an outer layer of polydopamine(PDA).Due to the existence of Ce6,the ZnO@Ce6-PDA can efficiently generate singlet oxygen(1O2)under 660 nm laser irradiation.Moreover,the ZnO@Ce6-PDA can serve as a photothermal agent,because of the excellent photothermal conversion efficiency of the PDA coating layer in the presence of 780 nm laser.Experiment results demonstrated that the designed nanotherapeutic agent had outstanding phototoxicity upon the combination of laser irradiation at 660 and 780 nm.Thus,our work proves that the ZnO@Ce6-PDA is a promising photodynamic/photothermal dual-modal nanotherapeutic agent for enhanced cancer therapy.     

Determination of the minimum temperature required for selective photothermal destruction of cancer cells with the use of immunotargeted gold nanoparticles

Laser photothermal therapy of cancer with the use of gold nanoparticles immunotargeted to molecular markers on the cell surface has been shown to be an effective modality to selectively kill cancer cells at much lower laser powers than those needed for healthy cells. To elucidate the minimum light dosimetry required to induce cell death, photothermal destruction of two cancerous cell lines and a noncancerous cell line treated with antiepidermal growth factor receptor (anti-EGFR) antibody-conjugated gold nanoparticles is studied, and a numerical heat transport model is used to estimate the local temperature rise within the cells as a result of the laser heating of the gold nanoparticles. It is found that cell samples with higher nanoparticle loading require a lower incident laser power to achieve a certain temperature rise. Numerically estimated temperatures of 70-80 degrees C achieved by heating the gold particles agree well with the measured threshold temperature for destruction of the cell lines by oven heating and those measured in an earlier nanoshell method. Specific binding of anti-EGFR antibody to cancerous cells overexpressing EGFR selectively increases the gold nanoparticle loading within cancerous cells, thus allowing the cancerous cells to be destroyed at lower laser power thresholds than needed for the noncancerous cells. In addition, photothermal therapy using gold nanoparticles requires lower laser power thresholds than therapies using conventional dyes due to the much higher absorption coefficient of the gold nanoparticles.     

TAT peptide-functionalized gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradiance

Gold nanoparticles have great potential in plasmonic photothermal therapy (photothermolysis), but their intracellular delivery and photothermolysis efficiency have yet to be optimized. We show that TAT-peptide-functionalized gold nanostars (NS) enter cells significantly more than bare or PEGylated NS. The cellular uptake mechanism involves actin-driven lipid raft-mediated macropinocytosis, where particles primarily accumulate in macropinosomes but may also leak out into the cytoplasm. After 4-h incubation of TAT-NS on BT549 breast cancer cells, photothermolysis was accomplished using 850 nm pulsed laser under 0.2 W/cm(2) irradiation, below the maximal permissible exposure of skin. These results demonstrate the enhanced intracellular delivery and efficient photothermolysis of TAT-NS, promising agents in cancer therapy.     

Synthesis method-dependent photothermal effects of colloidal solutions of platinum nanoparticles used in photothermal anticancer therapy

One of the most common anticancer therapies is photothermal therapy (PTT). The effectiveness of PTT depends on the photosensitizer being a molecule which is toxic for the cancer cells after electromagnetic wave irradiation. Therefore, a simulation of PTT was performed in this work on two colon cancer cells (SW480 and SW620) using platinum nanoparticles (Pt NPs). Interestingly, in the literature the dependence between the synthesis method and the photothermal properties of Pt NPs was not discussed. Consequently, in this paper, we evaluated the photothermal properties of Pt NPs synthesized by two different methods: polyol (PtI NPs) and green chemistry (PtII NPs). Scanning transmission electron microscopy revealed that the size of both Pt NPs obtained was 2 nm, the NPs were not agglomerated, and that the PtII NPs were distributed on green tea supports. The selected area electron diffraction and X-ray diffraction analysis confirmed the crystallinity of both types of Pt NPs. Fourier-transform infrared (FTIR) spectrum of the PtII NPs showed interactions between the NPs and stretching modes for C=O groups from flavonoids and polyphenols. Therefore, these chemical compounds could be responsible for reducing Pt⁴⁺ ions to Pt⁰. Moreover, the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay showed that the PtII NPs exhibited 10% and 20% better cytotoxicity effect on SW480 and SW620 cells, than PtI NPs. The viability of cancer cells decreased when Pt NPs were used in PTT. The highest percentage of dead cells (82%) was observed for PtII NPs and 650-nm laser irradiation. FTIR and Raman spectroscopy showed structural changes induced by both Pt NPs and laser irradiation of cells in the range corresponding to levels of DNA, phospholipids, proteins, and lipids. Moreover, the calculated photothermal conversion efficiency showed that the value of this parameter is around 35%, regardless of the synthesis method and used wavelengths.     

An endoplasmic reticulum-targeted organic photothermal agent for enhanced cancer therapy

Developing selectively targeted photothermal agents to reduce side effects in photothermal therapy remains a great challenge. Inspired by the key role of endoplasmic reticulum in the protein synthesis and intracellular signal transduction, particularly for the immunogenic cell death induced by endoplasmic reticulum stress, we developed an endoplasmic reticulum-targeted organic photothermal agent(Ts-PTRGD) for enhancing photothermal therapy of tumor. The photothermal agent was covalently attached...     

Ag@TiO2 Nanoprisms with Highly Efficient Near‐Infrared Photothermal Conversion for Melanoma Therapy

Melanoma is a primary reason of death from skin cancer and associated with high lethality. Photothermal therapy (PTT) has been developed into a powerful cancer treatment technique in recent years. Here, we created a low‐cost and high‐performance PTT agent, Ag@TiO₂ NPs, which possesses a high photothermal conversion efficiency of ≈65 % and strong near‐infrared (NIR) absorption about 808 nm. Ag NPs were synthesized using a two‐step method and coated with TiO₂ to obtain Ag@TiO₂ NPs by a facile sol‐gel method. Because of the oxide, Ag@TiO₂ NPs exhibit remarkable high photothermal conversion efficiencies and biocompatibility in vivo and in vitro. Cytotoxicity and therapeutic efficiency of photothermal cytotoxicity of Ag@TiO₂ NPs were tested in B16‐F10 cells and C57BL/6J mice. Under light irradiation, the elevated temperature causes cell death in Ag NPs‐treated (100 μg mL^?1) cells in vitro (both p<0.01). In the case of subcutaneous melanoma tumor model, Ag@TiO₂ NPs (100 μg mL^?1) were injected into the tumor and irradiated with a 808 nm laser of 2 W cm^?2 for 1 minute. As a consequence, the tumor volume gradually decreased by NIR laser irradiation with only a single treatment. The results demonstrate that Ag@TiO₂ NPs are biocompatible and an attractive photothermal agent for cutaneous melanoma by local delivery.     

铁掺杂的聚2-硝基-1,4-苯二胺纳米球的制备及在光热/光动力/化学动力学肿瘤治疗中的应用

肿瘤微环境(TME)的复杂性,使得单一治疗方式很难实现完全治愈。 为此,构建了一种负载吲哚菁绿(ICG)的铁掺杂的聚2-硝基-1,4-苯二胺多功能纳米球Fe-PNPD-ICG(FPIs),用于光热(PTT)/光动力(PDT)/化学动力学(CDT)的联合治疗。 在808 nm激光器照射下,ICG作为光敏剂可以产生单线态氧,铁掺杂的聚2-硝基-1,4-苯二胺纳米球作为光热剂具有36.65%的光热转换效率。 FPIs一旦内化到肿瘤内,由Fe³⁺/Fe²⁺转化引发Fenton反应产生·OH实现化学动力学治疗,反应过程中可以清除TME中过表达的谷胱甘肽(GSH),从而降低肿瘤中的抗氧化能力。 同时,产生的氧气可以改善TME中乏氧情况,增强PDT的治疗效果。 因此,FPIs是PTT/PDT/CDT联合治疗的一种理想材料,在肿瘤治疗中具有潜在的应用前景。     

A Novel Polysaccharide from Lentinus edodes Mycelia Exhibits Potential Antitumor Activity on Laryngeal Squamous Cancer Cell Line Hep-2

A novel polysaccharide [Lentinus edodes mycelia polysaccharide 2 (LMP2)] with a molecular weight of 2.27?×?10⁴ Da was isolated from the Lentinus edodes mycelia and purified by Sephadex G-200 and diethylaminoethyl-32 column chromatography. HPLC results indicated that LMP2 contained mannose, arabinose, galactose, xylose, and rhamnose with a relative molar ratio of 1:0.74:3.23:1.18:10.98. Its antitumor activity was evaluated in vitro by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, colony formation assay, and transwell assay. LMP2 showed a remarkable inhibitory effect on the proliferation of Hep-2 cells, and at the concentration of 200 mg/ml, the inhibition ratio was 37.2 % after 72 h. Furthermore, colony formation of Hep-2 cells was reduced significantly after treatment with LMP2. Invasion of Hep-2 cells was inhibited significantly by LMP2. These results suggested that LMP2 could be explored as a potential antitumor material for laryngeal carcinoma.